sheila kaplan katie thomasapril pacemakers artificial joints defibrillators dental fillings birth control pills vaccines made china could subject new tariffs dozens drugs medical devices among chinese products ingredients trump administration targeted potential percent tariff proposal week list includes products dangerously short supply like epinephrine used treat allergic reactions others like insulin whose rising prices driven public outrage united states proposed tariffs unsettled medical device supply industries given growing number products well components manufactured china recent years trade groups noted chinese manufacturing medical equipment undergone major shift throwaway items like surgical gloves complicated products like magnetic resonance imaging scanners china medical device industry expanding rapidly international trade commission report january said fastest growth sales implantable orthopedic devices plates screws mostly made titanium used surgery sports medicine one analyst estimates percent medical devices imported united states come china amounting billion year several companies including medtronic zimmer biomet orthopedic device factories china export goods united states medtronic considered world leading medical device maker bought china kanghui holdings major provider orthopedic devices china products shipped operations united states would subject tariffs medtronic declined comment saying still reviewing proposal report week rbc capital markets estimated proposed percent tariffs took effect move could cost medical device industry billion year higher costs would undoubtedly result increased prices devices affecting baby boomers among biggest recipients hip knee replacements brandon henry medical device analyst rbc capital markets said bigger medical technology companies surprised find products list greg crist spokesman advamed trade group device members said members disappointed action threatens affect health well american patients around world much would passed consumers remains unknown impact orthopedic device tariff straight line said david halsey president american academy orthopaedic surgeons email adding group working assess possible effects still unclear whether tariffs enacted companies may lobby administration changes friday president trump ratcheted pressure threatening levy tariffs additional billion imports provoking china respond would strike back yet indeed stocks drug manufacturers remained largely unruffled unveiling list tuesday friday major medical device company stocks dipped along overall market medtronic shares percent lower week zimmer biomet percent unclear whether tariffs would substantial effect drug industry analysts said even though china leading exporter raw pharmaceutical ingredients see much impact umer raffat pharmaceutical industry analyst evercore isi said note investors tuesday please verify youre robot clicking box invalid email address please enter must select newsletter subscribe view new york times newsletters many generic drugs contain chinese ingredients manufactured countries like india meaning would subject tariffs brand name drugs made united states frequently expensive list price often little connection product manufacturing cost nevertheless least one trade group sounded alarm tariffs warning could exacerbate already contentious issue health care costs trump administration pledged take action lower drug prices concerned proposed tariffs may lead increased costs manufacturing generics biosimilars thus higher prescription drug prices patients u said jeffrey k francer senior vice president general counsel association accessible medicines represents generic drug companies generic business struggling falling prices even brand name drug prices risen several major manufacturers including merck generic drug makers mylan teva pharmaceutical declined comment cynic thinks another way companies say need raise prices said erin r fox drug shortage expert university utah ms fox said suspected tariffs could exacerbate shortfalls generic injectable drugs decades old products mainstays hospitals short supply years manufacturing problems supply disruptions many pill forms generic drugs manufactured overseas generic injectable drugs made united states using raw ingredients acquired overseas many companies disclose raw ingredients come saying information proprietary hard know impact proposed tariffs ms fox said two drugs list chinese exports epinephrine lidocaine short supply sterile injectable form things bad right injectables need anything else pile possibly make things worse ms fox said heather zoumas lubeski spokeswoman par pharmaceutical major manufacturer injectable epinephrine said company raw ingredients imported europe proposed tariffs would impact par parent company endo international even widely used products unclear american consumers would affected insulin list three major companies sell insulin united states eli lilly sanofi novo nordisk said import insulin china novo nordisk said one rarely used insulin product novopen echo come china company committed keeping accessible consumers analysts trade lawyers pointed list early draft many different industries groups would lobbying government coming months products would punished earlier version article erroneously included pfizer among group manufacturers declined comment president trump proposal impose tariffs certain medical devices drugs made china pfizer contacted comment new york times version article appears print april page b new york edition headline need hip may cost order reprints todays paper subscribe interested feedback page tell us think go home page